Clozapine is an atypical antipsychotic that holds a unique role in the management of treatment‐resistant schizophrenia. Well known side‐effects include agranulocytosis and myocarditis but associated hepatic disorders are less familiar and listed under ‘rare or very rare’ by the British National Formulary.1 However, a transient elevation of transaminases has been estimated to affect up to 50% of patients treated with clozapine.2 This article describes a patient with minimally elevated LFTs who subsequently developed symptomatic hepatitis following the initiation of clozapine therapy.
IntroductionAntipsychotic drugs are known to reduce the seizure threshold. clozapine, a second-generation antipsychotic is most associated with causing convulsions.Case reportA 70-year old gentleman with a diagnosis of Paranoid Schizophrenia had been stable on a daily dose of clozapine 150 mg. The patient wished to stop clozapine for a number of reasons. His clozapine was stopped and he was titrated on to risperidone 3 mg daily. Two weeks after being on risperidone monotherapy the patient attended the emergency department following a fall. Within the department he had two witnessed seizures. Following normal investigations a diagnosis of risperidone induced seizures was made and the medication stopped.DiscussionThe incidence of seizures in non-epileptic patients attributed to the use of risperidone has been reported as 0.3%. The mechanism is unclear but it is interesting to note that a moderate risk of EEG abnormalities has been associated with it. Other risk factors such as old age and hypertension can also influence EEG changes. In contrast seizures with clozapine are dose-dependent (5% at doses above 600 mg/day) and associated with rapid titration. These effects are consistent with the process of kindling.ConclusionA reminder that all antipsychotics can cause seizures. Clozapine is most commonly associated but has specific risk factors. Consideration of patient specific pro-convulsive factors is required before prescribing antipsychotics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.